David Michael Wyatt

This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Pfizer Vaccines, Lcc. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Michael Wyatt. Retrieved from https://idiyas.com/inventor/david-michael-wyatt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 9.5

ph-index = 3

Forward Citations = 17(Granted Patents)

Company Filing History:

6 out of 8

Pfizer Vaccines, Lcc

patents

Years Active: 2012-2018

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9987341 - PCSK9 vaccine (2018-06-05),

2. 9481875 - PCSK9 vaccine (2016-11-01),

3. 9216229 - IgE CH3 peptide vaccine (2015-12-22),

4. 8889144 - PCSK9 vaccine (2014-11-18),

5. 8475801 - IgE CH3 peptide vaccine (2013-07-02),

6. 8298547 - IgE CH3 peptide vaccine (2012-10-30),

Title: David Michael Wyatt: Innovator in Vaccine Development

Introduction

David Michael Wyatt is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of vaccine development, holding a total of six patents. His work focuses on innovative solutions for medical challenges, particularly in the area of PCSK9-mediated disorders.

Latest Patents

Among his latest patents is the PCSK9 vaccine, which relates to the provision of novel immunogens. This invention comprises an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment, or alleviation of PCSK9-mediated disorders. The invention further details methods for the production of these medicaments, immunogenic compositions, and pharmaceutical compositions, along with their use in medicine.

Career Highlights

David Michael Wyatt is currently associated with Pfizer Vaccines, LLC, where he continues to advance his research and development efforts. His work at Pfizer has positioned him as a key player in the field of immunology and vaccine innovation.

Collaborations

He has collaborated with notable colleagues, including Brian Robert Champion and Alan Daniel Brown, contributing to a dynamic research environment that fosters innovation.

Conclusion

David Michael Wyatt's contributions to vaccine development, particularly through his work on the PCSK9 vaccine, highlight his role as a leading inventor in the medical field. His ongoing efforts at Pfizer Vaccines, LLC, and collaborations with esteemed colleagues further underscore his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.